... Disclosure prominence Fair balance Health risk disclosure Prescription drug advertising US prescription drug sales have tremendously grown from $285.7bn in 2008 to $325.8bn in 2012 (Mintel, 2014a). In this regard, research has suggested that consumer prescription drug advertising (DTCA...

... implications To ensure fair balance in prescription drug advertising, message designers should present a sufficient level of health risk disclosure prominence. Social implications To encourage consumers to make informed prescription drug decisions, health risk information provided through prescription...